This issue of McDermott’s Healthcare Regulatory Check-Up highlights significant regulatory activity for February 2023. We discuss several criminal and civil enforcement actions that involve Anti-Kickback Statute (AKS) and beneficiary inducement issues. We also highlight the recent Office of Inspector General (OIG) advisory opinions 23-01 and 23-02, as well as other notable developments, including the US Department of Justice (DOJ) False Claims Act (FCA) Report for FY 2022.
